Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers Identify Less Expensive HIV Progression Test as Effective as Current Tests in Use

17.10.2002


Heat-denatured p24 Antigen Tests Can Cut Cost of HIV Progression Monitoring



Researchers at the Johns Hopkins Bloomberg School of Public Health and the University of Zurich, Switzerland, have identified a test for monitoring the progression of HIV in the early stages of the disease that is less expensive than current tests used to monitor the progression of HIV. The test, called HIV-1 protein 24 (p24) antigen, predicts disease progression as well as CD4 lymphocyte count and HIV-1 RNA viral load, the measurements currently used to determine when patients should start antiviral drug therapy to prevent AIDS. The study, “Heat-Denatured Human Immunodeficiency Virus Type 1 Protein 24 Antigen: Prognostic Value in Adults with Early-Stage Disease,” appears in the Oct. 15 issue of The Journal of Infectious Diseases.

Timothy R. Sterling, MD, a study co-author and assistant professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health said, “The test could be used to determine when to initiate anti-retroviral therapy in HIV-infected persons. And because it costs much less than both CD4 lymphocyte count and HIV-1 RNA viral load, the heat-denatured p24 antigen test could be of particular benefit in developing countries, where the burden of HIV infection is great.”


According to Dr. Sterling, CD4 lymphocytes and HIV-1 RNA are excellent predictors of disease progression as well as a patient’s response to therapy and are used to determine when to initiate anti-retroviral therapy. However, the current tests to monitor CD4 lymphocytes and HIV-1 RNA are expensive. The heat-denatured assay separates antigen-antibody complexes and increases the detection of p24 antigen in patients during the early stages of the disease.

“P24 antigen is a protein in HIV. The test is administered by drawing blood from a patient, heating the plasma, and then measuring the amount of p24 antigen found in the sample. Higher levels of p24 indicates a greater risk of disease progression,” explained Dr. Sterling. The authors found that a p24 level of 5 pg/ml was comparable to a CD4 lymphocyte count of 350 cells/mm3 or a viral load of 30,000 copies/ml (b-DNA).

The 494 participants in the study were injection drug users enrolled in a longitudinal cohort study. Blood samples were obtained and analyzed to quantify T-cell subsets; then HIV-1 RNA and p24 antigen were quantified in specimens that had been frozen after collection. Semiannual follow-up interviews were also held with participants during the five-year study.

Using Johns Hopkins Hospital prices, researchers found that conducting a CD4 lymphocyte count is $88, whereas a HIV-1 RNA level costs $152. The total cost of a p24 antigen test is approximately $20 when used qualitatively and $30 when used quantitatively. Because of the frequency with which monitoring must be performed to assess disease progression and response to therapy, researchers said they believe the heat-denatured p24 antigen test would be much more affordable than the currently available tests. In addition, they said the p24 antigen assay is readily automated and easy to perform, and that storage is less demanding than that required for other tests.

Sterling said, “The heat-denatured p24 antigen test was comparable with that of the HIV-1 RNA and CD4 lymphocytes. In addition to its low cost, it could be used either alone, or in conjunction with the other tests. It would be very useful in making decisions regarding the initiation of anti-retroviral therapy, particularly in resource-poor settings.”

Co-Authors of the study were Donald R. Hoover, Jacquie Astemborski, David Vlahov, John G. Bartlett, and Jorg Schupbach.

The study was funded by the Swiss Federal Office of Public Health, Swiss Human Immunodeficiency Virus Cohort Study/Swiss National Science Foundation, National Institute on Drug Abuse, and National Institute of Allergy and Infectious Diseases.

Public Affairs Media Contacts for the Johns Hopkins Bloomberg School of Public Health: Tim Parsons or Kenna Brigham @ 410-955-6878 or paffairs@jhsph.edu.

Kenna L. Brigham | EurekAlert!
Further information:
http://www.journals.uchicago.edu/JID/home.html
http://www.jhsph.edu/Dept/EPI/index.html

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can the immune system be boosted against Staphylococcus aureus by delivery of messenger RNA?

Staphylococcus aureus is a feared pathogen (MRSA, multi-resistant S. aureus) due to frequent resistances against many antibiotics, especially in hospital infections. Researchers at the Paul-Ehrlich-Institut have identified immunological processes that prevent a successful immune response directed against the pathogenic agent. The delivery of bacterial proteins with RNA adjuvant or messenger RNA (mRNA) into immune cells allows the re-direction of the immune response towards an active defense against S. aureus. This could be of significant importance for the development of an effective vaccine. PLOS Pathogens has published these research results online on 25 May 2017.

Staphylococcus aureus (S. aureus) is a bacterium that colonizes by far more than half of the skin and the mucosa of adults, usually without causing infections....

Im Focus: A quantum walk of photons

Physicists from the University of Würzburg are capable of generating identical looking single light particles at the push of a button. Two new studies now demonstrate the potential this method holds.

The quantum computer has fuelled the imagination of scientists for decades: It is based on fundamentally different phenomena than a conventional computer....

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Marine Conservation: IASS Contributes to UN Ocean Conference in New York on 5-9 June

24.05.2017 | Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

 
Latest News

How herpesviruses win the footrace against the immune system

26.05.2017 | Life Sciences

Water forms 'spine of hydration' around DNA, group finds

26.05.2017 | Life Sciences

First Juno science results supported by University of Leicester's Jupiter 'forecast'

26.05.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>